Correlation Between QVC and Apogee Therapeutics,

Can any of the company-specific risk be diversified away by investing in both QVC and Apogee Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining QVC and Apogee Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between QVC Group and Apogee Therapeutics, Common, you can compare the effects of market volatilities on QVC and Apogee Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in QVC with a short position of Apogee Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of QVC and Apogee Therapeutics,.

Diversification Opportunities for QVC and Apogee Therapeutics,

-0.37

Correlation Coefficient

QVC  Apogee Therapeutics,

Very good diversification

The 3 months correlation between QVC and Apogee is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding QVC Group and Apogee Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Therapeutics, and QVC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on QVC Group are associated (or correlated) with Apogee Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Therapeutics, has no effect on the direction of QVC i.e., QVC and Apogee Therapeutics, go up and down completely randomly.

Pair Corralation between QVC and Apogee Therapeutics,

Assuming the 90 days horizon QVC Group is expected to under-perform the Apogee Therapeutics,. In addition to that, QVC is 2.87 times more volatile than Apogee Therapeutics, Common. It trades about -0.07 of its total potential returns per unit of risk. Apogee Therapeutics, Common is currently generating about 0.0 per unit of volatility. If you would invest  3,939  in Apogee Therapeutics, Common on May 4, 2025 and sell it today you would lose (164.00) from holding Apogee Therapeutics, Common or give up 4.16% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

QVC Group  vs.  Apogee Therapeutics, Common

QVC Group

Risk-Adjusted Performance

Very Weak

Over the last 90 days QVC Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in September 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Apogee Therapeutics,

Risk-Adjusted Performance

Very Weak

Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Apogee Therapeutics, is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with QVC and Apogee Therapeutics,

The main advantage of trading using opposite QVC and Apogee Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if QVC position performs unexpectedly, Apogee Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Therapeutics, will offset losses from the drop in Apogee Therapeutics,'s long position.

The idea behind QVC Group and Apogee Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.